TMC Life Sciences Bhd
KLSE:TMCLIFE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.5
0.805
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
TMC Life Sciences Bhd
Long-Term Debt
TMC Life Sciences Bhd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
TMC Life Sciences Bhd
KLSE:TMCLIFE
|
Long-Term Debt
myr188.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
159%
|
CAGR 10-Years
58%
|
|
|
H
|
Hong Seng Consolidated Bhd
KLSE:HONGSENG
|
Long-Term Debt
myr20.6m
|
CAGR 3-Years
92%
|
CAGR 5-Years
190%
|
CAGR 10-Years
6%
|
|
|
O
|
Optimax Holdings Bhd
KLSE:OPTIMAX
|
Long-Term Debt
myr27.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
D
|
DC Healthcare Holdings Bhd
KLSE:DCHCARE
|
Long-Term Debt
myr17.9m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
TMC Life Sciences Bhd
Glance View
TMC Life Sciences Bhd.operates as an investment holding company. The company is headquartered in Petaling Jaya, Selangor and currently employs 1,108 full-time employees. The company went IPO on 2005-10-06. The firm's subsidiaries include IVF Technologies Sdn. Bhd., which is a provision of fertility services and operation of women’s clinic; TMC Biotech Sdn. Bhd., which is a provision of fertility consultancy, laboratory and embryology services and research and development; TMC Lifestyle Sdn. Bhd., which is developing, marketing and management of healthcare programs; TMC Properties Sdn. Bhd., which is a property investment; Thomson TCM Sdn. Bhd., which is a provides traditional and complementary services; BB Waterfront Sdn. Bhd., which provides healthcare services, TMC Women’s Specialist Holdings Sdn. Bhd., which is in the business of operating fertility centers and providing related services, and TMC Care Sdn. Bhd., which is engaged in the provision of pharmacy services and products, and management support services.
See Also
What is TMC Life Sciences Bhd's Long-Term Debt?
Long-Term Debt
188.1m
MYR
Based on the financial report for Jun 30, 2024, TMC Life Sciences Bhd's Long-Term Debt amounts to 188.1m MYR.
What is TMC Life Sciences Bhd's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
58%
Over the last year, the Long-Term Debt growth was -7%. The average annual Long-Term Debt growth rates for TMC Life Sciences Bhd have been 3% over the past three years , 159% over the past five years , and 58% over the past ten years .
You don't have any saved screeners yet
